Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Urinary hydroxyproline in hyperthyroidism]

R Baleva

    Vutreshni Bolesti
    |January 1, 1977
    PubMed
    Summary

    Elevated urinary hydroxyproline levels indicate active hyperthyroidism, significantly decreasing after treatment. This biomarker helps differentiate thyroid conditions and monitor treatment effectiveness.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Primary hyperparathyroidism in childhood and adolescence].

    Vutreshni bolesti·1982
    Same author

    [Case of Hashimoto's toxicosis with occult thyroid carcinoma].

    Vutreshni bolesti·1981
    Same author

    [Biochemical and x-ray changes in thyroid osteopathy].

    Vutreshni bolesti·1978
    Same author

    [Regulation of bone metabolism and metabolic bone diseases].

    Vutreshni bolesti·1977
    Same author

    [Idiopathic osteoporosis at an early age].

    Vutreshni bolesti·1977
    Same author

    [Chronic recurrent pancreatitis with erosive gastritis in a patient with primary hyperparathyroidism].

    Vutreshni bolesti·1976

    Area of Science:

    • Biochemistry
    • Endocrinology
    • Metabolic Research

    Background:

    • Hydroxyproline is a key component of collagen, reflecting bone and connective tissue metabolism.
    • Thyroid hormones influence collagen turnover, but hydroxyproline excretion patterns in various endocrine and metabolic conditions require further clarification.

    Purpose of the Study:

    • To investigate urinary total hydroxyproline excretion in patients with hyperthyroidism compared to other endocrine and metabolic disorders.
    • To assess changes in hydroxyproline levels following therapeutic remission of hyperthyroidism.

    Main Methods:

    • Quantitative analysis of 24-hour urinary hydroxyproline excretion.
    • Comparative study involving patients with active hyperthyroidism, euthyroid struma, osteoporosis, diabetes mellitus, and primary hyperparathyroidism.
    • Statistical analysis to determine significant differences between groups.

    Main Results:

    • Patients with active hyperthyroidism exhibited significantly higher urinary hydroxyproline (56.01 ± 6.03 mg) compared to euthyroid subjects (17.52 ± 6.03 mg).
    • Hydroxyproline levels decreased significantly (16.74 ± 7.38 mg) after achieving therapeutic remission in hyperthyroid patients.
    • Elevated levels were also observed in primary hyperparathyroidism (121.60 ± 18.2 mg) and diabetes mellitus (51.10 ± 3.11 mg), while osteoporosis showed moderate elevation (25.83 ± 10.88 mg).

    Conclusions:

    • Urinary hydroxyproline is a valuable indicator of heightened collagen catabolism in active hyperthyroidism.
    • Hydroxyproline excretion normalizes upon successful therapeutic intervention for hyperthyroidism.
    • Distinct hydroxyproline excretion profiles aid in differentiating hyperthyroidism from other metabolic bone and endocrine conditions.

    Related Experiment Videos